Variant Gene Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs3218713
rs3218713
Cardiomyopathy, Familial Hypertrophic, 1 (disorder)
T 0.800 CausalMutation CLINVAR Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples. 27532257

2017

dbSNP: rs3218713
rs3218713
Cardiomyopathy, Familial Hypertrophic, 1 (disorder)
0.800 GeneticVariation UNIPROT Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics. 27854360

2017

dbSNP: rs3218713
rs3218713
Cardiomyopathy, Familial Hypertrophic, 1 (disorder)
T 0.800 CausalMutation CLINVAR Multidimensional structure-function relationships in human β-cardiac myosin from population-scale genetic variation. 27247418

2016

dbSNP: rs3218713
rs3218713
Cardiomyopathy, Familial Hypertrophic, 1 (disorder)
0.800 GeneticVariation UNIPROT ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing. 25356965

2015

dbSNP: rs3218713
rs3218713
Cardiomyopathy, Familial Hypertrophic, 1 (disorder)
T 0.800 CausalMutation CLINVAR Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity. 25611685

2015

dbSNP: rs3218713
rs3218713
Cardiomyopathy, Familial Hypertrophic, 1 (disorder)
T 0.800 CausalMutation CLINVAR Confirmation of cause and manner of death via a comprehensive cardiac autopsy including whole exome next-generation sequencing. 24298987

2014

dbSNP: rs3218713
rs3218713
Cardiomyopathy, Familial Hypertrophic, 1 (disorder)
0.800 GeneticVariation UNIPROT 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). 25173338

2014

dbSNP: rs3218713
rs3218713
Cardiomyopathy, Familial Hypertrophic, 1 (disorder)
0.800 GeneticVariation UNIPROT ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. 23788249

2013

dbSNP: rs3218713
rs3218713
Cardiomyopathy, Familial Hypertrophic, 1 (disorder)
T 0.800 CausalMutation CLINVAR Genetic complexity in hypertrophic cardiomyopathy revealed by high-throughput sequencing. 23396983

2013

dbSNP: rs3218713
rs3218713
Cardiomyopathy, Familial Hypertrophic, 1 (disorder)
T 0.800 CausalMutation CLINVAR Uptake of cardiac screening and genetic testing among hypertrophic and dilated cardiomyopathy families. 23054336

2013

dbSNP: rs3218713
rs3218713
Cardiomyopathy, Familial Hypertrophic, 1 (disorder)
T 0.800 CausalMutation CLINVAR Early results of sarcomeric gene screening from the Egyptian National BA-HCM Program. 23233322

2013

dbSNP: rs3218713
rs3218713
Cardiomyopathy, Familial Hypertrophic, 1 (disorder)
T 0.800 CausalMutation CLINVAR A systematic approach to assessing the clinical significance of genetic variants. 24033266

2013

dbSNP: rs3218713
rs3218713
Cardiomyopathy, Familial Hypertrophic, 1 (disorder)
T 0.800 CausalMutation CLINVAR Screening of MYH7, MYBPC3, and TNNT2 genes in Brazilian patients with hypertrophic cardiomyopathy. 24093860

2013

dbSNP: rs3218713
rs3218713
Cardiomyopathy, Familial Hypertrophic, 1 (disorder)
T 0.800 CausalMutation CLINVAR Multiple gene mutations, not the type of mutation, are the modifier of left ventricle hypertrophy in patients with hypertrophic cardiomyopathy. 23283745

2013

dbSNP: rs3218713
rs3218713
Cardiomyopathy, Familial Hypertrophic, 1 (disorder)
0.800 GeneticVariation UNIPROT Clinical utility gene card for: hypertrophic cardiomyopathy (type 1-14). 21267010

2011

dbSNP: rs3218713
rs3218713
Cardiomyopathy, Familial Hypertrophic, 1 (disorder)
T 0.800 CausalMutation CLINVAR ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007. 18414213

2008

dbSNP: rs3218713
rs3218713
Cardiomyopathy, Familial Hypertrophic, 1 (disorder)
0.800 GeneticVariation UNIPROT Gene mutations in apical hypertrophic cardiomyopathy. 16267253

2005

dbSNP: rs3218713
rs3218713
Cardiomyopathy, Familial Hypertrophic, 1 (disorder)
0.800 GeneticVariation UNIPROT Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy. 15358028

2004

dbSNP: rs3218713
rs3218713
Cardiomyopathy, Familial Hypertrophic, 1 (disorder)
0.800 GeneticVariation UNIPROT Mutation spectrum in a large cohort of unrelated consecutive patients with hypertrophic cardiomyopathy. 12974739

2003

dbSNP: rs3218713
rs3218713
Cardiomyopathy, Familial Hypertrophic, 1 (disorder)
0.800 GeneticVariation UNIPROT Mutations of the beta myosin heavy chain gene in hypertrophic cardiomyopathy: critical functional sites determine prognosis. 12975413

2003

dbSNP: rs3218713
rs3218713
Cardiomyopathy, Familial Hypertrophic, 1 (disorder)
T 0.800 GeneticVariation CLINVAR Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. 12707239

2003

dbSNP: rs3218713
rs3218713
Cardiomyopathy, Familial Hypertrophic, 1 (disorder)
0.800 GeneticVariation UNIPROT Identification of the genotypes causing hypertrophic cardiomyopathy in northern Sweden. 12818575

2003

dbSNP: rs3218713
rs3218713
Cardiomyopathy, Familial Hypertrophic, 1 (disorder)
0.800 GeneticVariation UNIPROT Outcome of clinical versus genetic family screening in hypertrophic cardiomyopathy with focus on cardiac beta-myosin gene mutations. 12566107

2003

dbSNP: rs3218713
rs3218713
Cardiomyopathy, Familial Hypertrophic, 1 (disorder)
T 0.800 CausalMutation CLINVAR Mutations of the beta myosin heavy chain gene in hypertrophic cardiomyopathy: critical functional sites determine prognosis. 12975413

2003

dbSNP: rs3218713
rs3218713
Cardiomyopathy, Familial Hypertrophic, 1 (disorder)
0.800 GeneticVariation UNIPROT Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. 12707239

2003